Terms ending in 2028
Every in-force patent on Arkray, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D699,357 | Glucometer In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US D700,342 | Blood Glucose Test Meter In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,430,999 | Method for Detecting Sample Supply Condition, and Analyzer In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,268,625 | Method of Measuring Glycated Hemoglobin Concentration and Concentration Measuring Apparatus In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,293,194 | Analyzer In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,460,616 | Analyzer, Method for Cleaning Photometry Mechanism in Such Analyzer, and Cleaning Tool In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,900,844 | Glucose Dehydrogenase In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 8,008,085 | Method of Measuring HBA1C In force · High confidence | Arkray, Inc. | In force | High confidence | |
| US 9,410,184 | Glucose Dehydrogenase In force · High confidence | ARKRAY, Inc. | In force | High confidence | |
| US 8,637,275 | Postprandial Hyperglycemia Marker, Method of Measuring the Same, and Usage Thereof In force · High confidence | Arkray, Inc. | In force | High confidence | |
| 13 more term ends in 2028 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23, including 5 expiring within the 18 months from Nov 17, 2026.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.